| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Erythropoietic response and outcomes in kidney disease and type 2 diabetes.
|
N Engl J Med
|
2010
|
5.48
|
|
2
|
Longitudinal and circumferential strain rate, left ventricular remodeling, and prognosis after myocardial infarction.
|
J Am Coll Cardiol
|
2010
|
2.29
|
|
3
|
Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD.
|
Am J Kidney Dis
|
2011
|
2.05
|
|
4
|
Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both.
|
Circulation
|
2010
|
2.00
|
|
5
|
Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience.
|
Circulation
|
2011
|
1.87
|
|
6
|
Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999.
|
Blood
|
2010
|
1.79
|
|
7
|
Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease Study equation.
|
Am Heart J
|
2011
|
1.71
|
|
8
|
The inter-relationship of diabetes and left ventricular systolic function on outcome after high-risk myocardial infarction.
|
Eur J Heart Fail
|
2010
|
1.55
|
|
9
|
Calibrating parametric subject-specific risk estimation.
|
Biometrika
|
2010
|
1.54
|
|
10
|
Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection.
|
J Acquir Immune Defic Syndr
|
2011
|
1.52
|
|
11
|
Identification of potentially avoidable hospitalizations in patients with GI cancer.
|
J Clin Oncol
|
2014
|
1.51
|
|
12
|
Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection.
|
J Acquir Immune Defic Syndr
|
2012
|
1.44
|
|
13
|
Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm.
|
Am J Kidney Dis
|
2012
|
1.38
|
|
14
|
Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial.
|
Biol Blood Marrow Transplant
|
2010
|
1.34
|
|
15
|
Mechanical dyssynchrony after myocardial infarction in patients with left ventricular dysfunction, heart failure, or both.
|
Circulation
|
2010
|
1.24
|
|
16
|
Utilizing the integrated difference of two survival functions to quantify the treatment contrast for designing, monitoring, and analyzing a comparative clinical study.
|
Clin Trials
|
2012
|
1.22
|
|
17
|
Effects of bracing in adolescents with idiopathic scoliosis.
|
N Engl J Med
|
2014
|
1.18
|
|
18
|
Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo study.
|
Eur Heart J
|
2008
|
1.16
|
|
19
|
Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: an analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT).
|
Am Heart J
|
2011
|
1.15
|
|
20
|
Functional pathway analysis in acute myeloid leukemia using single cell network profiling assay: effect of specimen source (bone marrow or peripheral blood) on assay readouts.
|
Cytometry B Clin Cytom
|
2012
|
1.08
|
|
21
|
Interinstitutional variation in management decisions for treatment of 4 common types of cancer: A multi-institutional cohort study.
|
Ann Intern Med
|
2014
|
1.05
|
|
22
|
Dyssynchrony, contractile function, and response to cardiac resynchronization therapy.
|
Circ Heart Fail
|
2011
|
1.05
|
|
23
|
Mortality rates in trials of subjects with type 2 diabetes.
|
J Am Heart Assoc
|
2012
|
1.04
|
|
24
|
Nivolumab in Nonsquamous Non-Small-Cell Lung Cancer.
|
N Engl J Med
|
2016
|
0.99
|
|
25
|
Development and validation of diagnostic prediction model for solitary pulmonary nodules.
|
Respirology
|
2007
|
0.98
|
|
26
|
Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
|
Am J Kidney Dis
|
2009
|
0.95
|
|
27
|
Impact of gene expression profiling-based risk stratification in patients with myeloma receiving initial therapy with lenalidomide and dexamethasone.
|
Blood
|
2011
|
0.95
|
|
28
|
Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial.
|
Eur Heart J
|
2011
|
0.92
|
|
29
|
Darbepoetin alfa impact on health status in diabetes patients with kidney disease: a randomized trial.
|
Clin J Am Soc Nephrol
|
2011
|
0.90
|
|
30
|
Alternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority Studies.
|
Ann Intern Med
|
2015
|
0.89
|
|
31
|
Outcome prediction in sepsis combined use of genetic polymorphisms - A study in Japanese population.
|
Cytokine
|
2011
|
0.86
|
|
32
|
Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer.
|
Breast Cancer Res Treat
|
2005
|
0.85
|
|
33
|
Diagnostic performance of PET/CT in differentiation of malignant and benign non-solid solitary pulmonary nodules.
|
Ann Nucl Med
|
2008
|
0.85
|
|
34
|
Financial hardship and the intensity of medical care received near death.
|
Psychooncology
|
2014
|
0.84
|
|
35
|
Prediction of lung adenocarcinoma without vessel invasion: a CT scan volumetric analysis.
|
Chest
|
2005
|
0.83
|
|
36
|
Impact of high-risk classification by FISH: an eastern cooperative oncology group (ECOG) study E4A03.
|
Br J Haematol
|
2011
|
0.83
|
|
37
|
Clinical value of minor responses after 4 doses of rituximab in Waldenström macroglobulinaemia: a follow-up of the Eastern Cooperative Oncology Group E3A98 trial.
|
Br J Haematol
|
2009
|
0.81
|
|
38
|
Opposing effects of β blockers and angiotensin-converting enzyme inhibitors on development of new-onset diabetes mellitus in patients with stable coronary artery disease.
|
Am J Cardiol
|
2011
|
0.80
|
|
39
|
Prediction of response and prognostic factors for Ewing family of tumors in a low incidence population.
|
J Cancer Res Clin Oncol
|
2007
|
0.79
|
|
40
|
Clinical consequences of road traffic injuries among the elderly in Japan.
|
BMC Public Health
|
2010
|
0.78
|
|
41
|
Development and verification of a prediction model using serum tumor markers to predict the response to chemotherapy of patients with metastatic or recurrent breast cancer.
|
J Cancer Res Clin Oncol
|
2008
|
0.78
|
|
42
|
Suppression of aldosterone mediates regression of left ventricular hypertrophy in patients with hypertension.
|
J Renin Angiotensin Aldosterone Syst
|
2011
|
0.77
|
|
43
|
The short treatment with the angiotensin receptor blocker candesartan surveyed by telemedicine (STAR CAST) study: rationale and study design.
|
Hypertens Res
|
2008
|
0.76
|
|
44
|
Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapy.
|
Breast Cancer Res Treat
|
2006
|
0.76
|
|
45
|
Long-term nitrite inhalant exposure and cancer risk in MSM.
|
AIDS
|
2017
|
0.75
|
|
46
|
Detecting Lung and Colorectal Cancer Recurrence Using Structured Clinical/Administrative Data to Enable Outcomes Research and Population Health Management.
|
Med Care
|
2015
|
0.75
|
|
47
|
Predicted Interval Plots (PIPS): A Graphical Tool for Data Monitoring of Clinical Trials.
|
Stat Biopharm Res
|
2009
|
0.75
|
|
48
|
Circumstances and outcomes of sudden unexpected death in patients with high-risk myocardial infarction: implications for prevention.
|
Circulation
|
2011
|
0.75
|
|
49
|
Detecting Lung and Colorectal Cancer Recurrence Using Structured Clinical/Administrative Data to Enable Outcomes Research and Population Health Management.
|
Med Care
|
2017
|
0.75
|
|
50
|
Genomic characterization of multiple clinical phenotypes of cancer using multivariate linear regression models.
|
Bioinformatics
|
2007
|
0.75
|